NRGEX | SBASX | NRGEX / SBASX | |
Total Expense Ratio | 0.03 | 0.99 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 1.13 | 61% |
Fund Existence | 4 years | 6 years | - |
Gain YTD | -2.763 | 1.981 | -139% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.78B | 95.7M | 9,173% |
Annual Yield % from dividends | 0.54 | 0.22 | 247% |
Returns for 1 year | -8.44 | -3.66 | 231% |
Returns for 3 years | 13.53 | 29.63 | 46% |
Returns for 5 years | N/A | 22.64 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JCVIX | 25.32 | 0.43 | +1.73% |
JHancock Classic Value I | |||
SBHIX | 24.28 | 0.14 | +0.58% |
Saratoga Health & Biotechnology I | |||
ETLAX | 15.81 | 0.03 | +0.19% |
Eventide Large Cap Focus A | |||
EKBAX | 15.66 | -0.06 | -0.38% |
Allspring Diversified Cap Bldr A | |||
PRJQX | 49.66 | -0.45 | -0.90% |
PGIM Jennison Global Opportunities R6 |